α-Synuclein antisense oligonucleotides as a disease-modifying therapy for Parkinson’s diseaseTracy Cole, Katrina L. Paumier|JCI Insight|2021Cited by 136
Apolipoprotein E4 Reduction with Antisense Oligonucleotides Decreases Neurodegeneration in a Tauopathy ModelAlexandra Litvinchuk, David M. Holtzman, Yang Shi et al.|Annals of Neurology|2021Cited by 80
Alpha-synuclein antisense oligonucleotides as a disease-modifying therapy for Parkinson’s diseaseTracy Cole, Katrina L. Paumier|bioRxiv (Cold Spring Harbor Laboratory)|2019Cited by 10